Decitabine
NDC 67184-0535, decitabine, injection, powder, lyophilized, for solution, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0535
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212826
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DECITABINE50 mg/20mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0535-1 | 67184053501 | 1 VIAL in 1 CARTON (67184-0535-1) / 20 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5b2dce6f-c715-47dc-971e-06244ccd7548
Use it
Look up 67184-0535 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0535. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.